Charco Neurotech
Pre-clinicalThe CUE1 and CUE1+ by Charco Neurotech offers a novel, non-invasive approach to increasing quality of life for people with Parkinson's.
Founded
2019
Focus
NeuroscienceMedical Devices
About
The CUE1 and CUE1+ by Charco Neurotech offers a novel, non-invasive approach to increasing quality of life for people with Parkinson's.
Funding History
2Total raised: $1.7M
Grant$500KNational Institute for Health and Care ResearchJan 15, 2022
Seed$1.2MParkwalk AdvisorsMar 15, 2021
Company Info
TypePrivate
Founded2019
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile